CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
vascular occlusion test +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01848977
NCT01848977N/ACompleted
CompareCT.gov

Comparison of Two Devices Using Near-infra Red Spectroscopy for the Measurement of Tissue Oxygenation During a Vascular Occlusion Test (INVOS® Versus Inspectra™)

Seoul National University Hospital·interventional·Posted May 8, 2013·Updated Jan 26, 2015

In Brief

A clinical study evaluating vascular occlusion test for Healthy. Completed, enrolled 20 participants.

Detailed Summary

Tissue oxygen saturation is non-invasively measured using near-infrared spectroscopy, by two device, INVOS®(somanetics Corporation, USA ) and InSpectra™ (Hutchinson Technology, USA). Each probes are attached to both thenar muscles and vascular occlusion test (VOT) is performed. The investigators will compare the Invos® data to InSpectra™ to investigate whether tissue oxygen saturation values by INVOS® can substitute for InSpectra™.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 8, 2013
Enrollment StartJan 1, 2013
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 13.2 years ago

Interventions

vascular occlusion testdevice

Using Invos® probe attacted to one thenar muscle, tissue oxgyenation is measured by VOT.

vascular occlusion testdevice

Using Inspectra™ probe attacted to another thenar muscle, tissue oxgyenation is measured by VOT.